Prostate Cancer study: AI
Official title Investigation of Impact of AI on Prostate Cancer Workflow
ClinicalTrials.gov ID: NCT07084779
What this study is testing
- What it's testing
- This study is testing whether AI software can detect prostate cancer lesions on MRI better than a radiologist alone.
- Who it's for
- You may be able to join if you are having an MRI before a prostate biopsy because doctors suspect prostate cancer.
- What's involved
- You will have your usual MRI and biopsy. A radiologist will read the images alone, then with AI help, and the AI will also give its own scores. You may have up to two extra biopsy spots if the AI finds them. Your images will be sent de‑identified to the company for research.
- Time commitment
- The study lasts for the time of your MRI and biopsy visit, with no extra visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 to 80
You may be able to join if
- Plan of care is to undergo a biopsy of the prostate after a pre-biopsy MRI
- Age 55-80
- Prostate-specific antigen (PSA) between 3-10 ng/mL
- No prior diagnosis or treatment of prostate cancer
You likely can't join if
- Pre-biopsy MRI is of low quality
- PI-QUAL score of 1 using PI-QUAL version 2
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.